ZG
Zahoor Ganie
About Zahoor Ganie
Data last updated:
Zahoor Ganie is an Additional Director at Spenduo Pharmaceuticals Private Limited (since 2020) and Designated Partner at Arance India Pharmaceuticals Llp (since 2021). The companies operate in Food And Beverages and Chemicals. The largest current company by reported revenue is Spenduo Pharmaceuticals Private Limited at ₹39.2 Lakh (FY 2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Spenduo Pharmaceuticals Private Limited U24304GJ2019PTC109136 | Additional Director | 19 Aug 2020 | 2019 | ₹39.2 Lakh (FY 2020) | Active |
| Arance India Pharmaceuticals Llp AAZ-8372 | Designated Partner | 10 Dec 2021 | 2021 | Active |
Board colleagues of Zahoor Ganie
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abdul Hamid War | 08512661 | Spenduo Pharmaceuticals Private Limited , Arance India Pharmaceuticals Llp | Director |
| Riyaz Ahmad Riyazi | 08898039 | Spenduo Pharmaceuticals Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Zahoor Ganie
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zahoor Ganie
Zahoor Ganie currently holds 2 directorships: Spenduo Pharmaceuticals Private Limited (Additional Director, since 19 Aug 2020, revenue ₹39.2 Lakh (FY 2020)); Arance India Pharmaceuticals Llp (Designated Partner, since 10 Dec 2021).
Zahoor Ganie was first appointed on 19 Aug 2020 as Additional Director at Spenduo Pharmaceuticals Private Limited. The most recent appointment on record is 10 Dec 2021 at Arance India Pharmaceuticals Llp.
The current boards of Zahoor Ganie's companies include Abdul Hamid War (Spenduo Pharmaceuticals Private Limited), Riyaz Ahmad Riyazi (Spenduo Pharmaceuticals Private Limited).